BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16532512)

  • 1. Screening of siRNA target sequences by using fragmentized DNA.
    Kasim V; Taira K; Miyagishi M
    J Gene Med; 2006 Jun; 8(6):782-91. PubMed ID: 16532512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A plasmid-based system for expressing small interfering RNA libraries in mammalian cells.
    Kaykas A; Moon RT
    BMC Cell Biol; 2004 Apr; 5():16. PubMed ID: 15119963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
    Luo Q; Kang Q; Song WX; Luu HH; Luo X; An N; Luo J; Deng ZL; Jiang W; Yin H; Chen J; Sharff KA; Tang N; Bennett E; Haydon RC; He TC
    Gene; 2007 Jun; 395(1-2):160-9. PubMed ID: 17449199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.
    Choi I; Cho BR; Kim D; Miyagawa S; Kubo T; Kim JY; Park CG; Hwang WS; Lee JS; Ahn C
    J Biotechnol; 2005 Nov; 120(3):251-61. PubMed ID: 16095743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells.
    Miyagishi M; Sumimoto H; Miyoshi H; Kawakami Y; Taira K
    J Gene Med; 2004 Jul; 6(7):715-23. PubMed ID: 15241778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry for assessment of the efficacy of siRNA.
    Ho HY; Cheng ML; Wang YH; Chiu DT
    Cytometry A; 2006 Oct; 69(10):1054-61. PubMed ID: 16998867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
    Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
    J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNAi expression vectors in mammalian cells.
    Miyagishi M; Taira K
    Methods Mol Biol; 2004; 252():483-91. PubMed ID: 15017073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primer extension-based method for the generation of a siRNA/miRNA expression vector.
    Gou D; Zhang H; Baviskar PS; Liu L
    Physiol Genomics; 2007 Nov; 31(3):554-62. PubMed ID: 17804605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective gene suppression using small interfering RNA in hard-to-transfect human T cells.
    Yin J; Ma Z; Selliah N; Shivers DK; Cron RQ; Finkel TH
    J Immunol Methods; 2006 May; 312(1-2):1-11. PubMed ID: 16603179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [siRNA-mediated silencing of ClC-2 gene inhibits proliferation of human U-87 glioma cells].
    Yang XY; Lai XG; Zhang Y; Pei JM; Yang AG; Zhou SS
    Ai Zheng; 2006 Jul; 25(7):805-10. PubMed ID: 16831268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic production of RNAi libraries from cDNAs.
    Shirane D; Sugao K; Namiki S; Tanabe M; Iino M; Hirose K
    Nat Genet; 2004 Feb; 36(2):190-6. PubMed ID: 14704669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of assembly of siRNA elements into RNA-induced silencing complex by fork-siRNA duplex carrying nucleotide mismatches at the 3'- or 5'-end of the sense-stranded siRNA element.
    Ohnishi Y; Tokunaga K; Hohjoh H
    Biochem Biophys Res Commun; 2005 Apr; 329(2):516-21. PubMed ID: 15737617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vector-based in vivo RNA interference: dose- and time-dependent suppression of transgene expression.
    Kobayashi N; Matsui Y; Kawase A; Hirata K; Miyagishi M; Taira K; Nishikawa M; Takakura Y
    J Pharmacol Exp Ther; 2004 Feb; 308(2):688-93. PubMed ID: 14610223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The construction and identification of siRNA expression vector against hypoxia inducible factor -1 alpha in vitro].
    He LF; Chen KZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):60-4. PubMed ID: 18289474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling reveals off-target gene regulation by RNAi.
    Jackson AL; Bartz SR; Schelter J; Kobayashi SV; Burchard J; Mao M; Li B; Cavet G; Linsley PS
    Nat Biotechnol; 2003 Jun; 21(6):635-7. PubMed ID: 12754523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The factors that contribute to the long-term expression of siRNA.
    Shiota M; Ikeda Y; Wadhwa R
    Nucleic Acids Symp Ser (Oxf); 2006; (50):243-4. PubMed ID: 17150908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel methods for expressing RNA interference in human cells.
    Sano M; Kato Y; Akashi H; Miyagishi M; Taira K
    Methods Enzymol; 2005; 392():97-112. PubMed ID: 15644177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.